Data

COVID vaccine efficacy against severe illness just under 50%, per early estimates from 2023 Two European observational studies estimate the vaccine effectiveness (VE) of the COVID-19 XBB.1.5 vaccine approved in fall 2023 against hospitalization, the first one finding 49% overall VE in adults, and one showing good protection—but uneven uptake—among pregnant women. CIDRAP

...

Socioeconomic disadvantage magnifies COVID-19 effects, slows recovery, data suggest Recovery from COVID-19 takes longer, and infection has a greater effect on health-related quality of life (HRQoL), among socioeconomically disadvantaged patients, suggests an observational study published in BMC Infectious Diseases. CIDRAP

...

Intersection of long COVID and disability highlighted in CDC study (medicalxpress.com)

Just as coronavirus transmission fluctuated in waves, so too have our responses to it. The world is four years from the acute phase of the pandemic, but not without lasting impact—including those who have maintained debilitating symptoms from COVID, adding to a large population of people with disabilities.

...

The largest study conducted by the CDC to capture the scope of disability in the U.S. and representing 245 million people, the authors found that nearly half of those over 65 reported being disabled, and that long COVID symptoms were present in 11% of those who reported disabilities, versus 7% of those without disabilities.

...